Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients

Published:2013-09-05 Issue:5b Volume:113 Page:E17-E21
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Thompson R. Houston¹,Boorjian Stephen A.¹,Kim Simon P.²,Cheville John C.³,Thapa Prabin⁴,Tarrel Robert⁴,Dronca Roxana⁵,Costello Brian⁵,Frank Igor¹

Affiliation:

1. Department of Urology; Mayo Clinic and Mayo Medical School; Rochester MN USA

2. Department of Urology; Yale University; New Haven CT USA

3. Department of Pathology; Mayo Clinic and Mayo Medical School; Rochester MN USA

4. Department of Health Sciences Research; Mayo Clinic and Mayo Medical School; Rochester MN USA

5. Department of Oncology; Mayo Clinic and Mayo Medical School; Rochester MN USA

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12274/fullpdf

Reference13 articles.

1. Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer;Sternberg;Urology,2007

2. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003

3. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration;Eur Urol,2005

4. Bladder cancer;Montie;J Natl Compr Canc Netw,2009

5. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy;Galsky;Lancet Oncol,2011

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomograms to Appraise The Risk of Chronic Kidney Disease After Radical Cystectomy: Shifting The Focus to Prevention;Clinical Genitourinary Cancer;2024-12

2. Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis;The French Journal of Urology;2024-09

3. Contemporary Molecular Markers for Predicting Systemic Treatment Response in Urothelial Bladder Cancer: A Narrative Review;Cancers;2024-09-01

4. Cisplatin eligibility in the neoadjuvant setting of patients with muscle-invasive bladder cancer undergoing radical cystectomy;The Oncologist;2024-07-02

5. Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant Treatment Quality in Patients With Muscle Invasive Bladder Cancer;Clinical Genitourinary Cancer;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3